Enzolytics Inc.
ENZCOTCHealthcare● Active
$0.00
+$0.00(+10.00%)
Market Cap$4335804
P/E Ratio—
52W High$0.0012
52W Low$0.0002
Enzolytics Inc. (ENZC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ENZC · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) | $0.00B |
| Gross Margin %(computed) | — | — | 58.16% | — | 91.52% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — | — | — | -705.50% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | — | — | — | -334.50% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| Wtd Avg Shares | 3.44B | 1.29B | 2.93B | 2.82B | 2.80B |
| EBITDA | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | — | -306.00% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Enzolytics Inc. data
About Enzolytics Inc. (ENZC) Income Statement
Enzolytics Inc. (ENZC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ENZC reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.00B) — a net profit margin of —.
Frequently asked questions
ENZC · 4 questionsEnzolytics Inc. (ENZC) reported revenue of $0.00B for 2025, down —% year-over-year.
ENZC revenueENZC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09